The efficacy and safety of sacubitril/valsartan in chronic kidney disease: a systematic review and meta-analysis

被引：0
作者：
Wei Zhou
Xinyue Yang
JingJing Jin
Meijuan Cheng
Yajing Li
Yaling Bai
Jinsheng Xu
机构：
[1] Hebei Clinical Research Center for Chronic Kidney Disease,Departments of Nephrology, The Fourth Hospital of Hebei Medical University, Hebei Key Laboratory of Vascular Calcification in Kidney Disease
来源：
International Urology and Nephrology | 2024年 / 56卷
关键词：
Sacubitril/valsartan; Chronic kidney disease; Efficacy; Safety; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：181 / 190
页数：9
相关论文
共 276 条
  • [1] Kuang H(2021)Sacubitril/valsartan in chronic kidney disease: from pharmacological mechanism to clinical application Eur J Pharmacol 907 174288-1172
  • [2] Huang X(2021)Effects of SGLT2 inhibitors on renal outcomes in patients with chronic kidney disease: a meta-analysis Front Med 8 728089-1245
  • [3] Zhou Z(2021)Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options Circulation 143 1157-517
  • [4] Cheng X(2020)Effects of sacubitril/valsartan in patients with heart failure and chronic kidney disease: a meta-analysis Eur J Pharmacol 884 173444-498
  • [5] Xu G(2021)Effect of angiotensin–neprilysin versus renin–angiotensin system inhibition on renal outcomes: a systematic review and meta-analysis Front Pharmacol 12 604017-652
  • [6] Li N(2020)Angiotensin–neprilysin inhibition and renal outcomes in heart failure with preserved ejection fraction Circulation 142 1236-1514
  • [7] Lv D(2015)Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction Eur J Heart Fail 17 510-565
  • [8] Zhu X(2018)Renal effects and associated outcomes during angiotensin–neprilysin inhibition in heart failure JACC Heart Fail 6 489-1395
  • [9] Wei P(2019)Sacubitril/valsartan in chronic kidney disease, the nephrologist point of view Nefrologia 39 646-548
  • [10] Gui Y(2018)Effects of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease Circulation 138 1505-1620
12345678910